phorbolol myristate acetate has been researched along with indomethacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belizario, JE; Dinarello, CA | 1 |
| Ikawa, Y; Mutoh, N; Ohki, E; Sato, H; Shiba, K; Suzuki, M; Ueno, K | 1 |
2 other study(ies) available for phorbolol myristate acetate and indomethacin
| Article | Year |
|---|---|
Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
Topics: Animals; Cell Cycle; Cholera Toxin; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Fibrosarcoma; G1 Phase; Humans; Indomethacin; Interleukin-1; Interleukin-6; Mice; Premedication; Tetradecanoylphorbol Acetate; Time Factors; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1991 |
Comparative study of histamine H4 receptor expression in human dermal fibroblasts.
Topics: Cells, Cultured; Dexamethasone; Fibroblasts; Gene Expression; Histamine; Humans; Indomethacin; Lipopolysaccharides; Receptors, Histamine; Tetradecanoylphorbol Acetate | 2008 |